StockData
Quoin Pharmaceuticals Ltd. logo

Quoin Pharmaceuticals Ltd. (QNRX) stock

QNRXNasdaqPharmaceutical Preparations
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 5, 2026Score 6/30
$3.28−0.08 (-2.35%)

Close on Nov 20, 2026Market cap $6.59MP/E –Yield –

Quoin Pharmaceuticals shares outstanding

Diluted shares outstanding: the weighted share count used for earnings per share, adjusted for stock splits.

For fiscal 2021 it was 1.58B, up 31.9% from the year before. The highest annual figure on record is 1.58B in fiscal 2021.

Annual shares outstanding

PeriodPeriod endValueChange
FY2021Dec 31, 20211.58B+31.9%
FY2020Dec 31, 20201.20B0.0%
FY2019Dec 31, 20191.20B+828.3%
FY2018Dec 31, 2018129M+15.6%
FY2017Dec 31, 2017112M+22.9%
FY2016Dec 31, 201691M+22.4%
FY2015Dec 31, 201574M–

More Quoin Pharmaceuticals figures

See a number that looks wrong?